DiaMedica Therapeutics (DMAC) Non Operating Income (2018 - 2025)
DiaMedica Therapeutics' (DMAC) quarterly Non Operating Income came in at $483000.0 in Q4 2025, down 8.52% year-on-year from $528000.0 in Q4 2024, and up 15.27% quarter-over-quarter from $419000.0 in Q3 2025.
DiaMedica Therapeutics (DMAC) Non Operating Income (2018 - 2025) Analysis & Trends
DiaMedica Therapeutics' Non Operating Income history runs 8 years deep, the most recent figure standing at $483000.0 for Q4 2025.
- On a quarterly basis, Non Operating Income fell 8.52% year-over-year to $483000.0 in Q4 2025; TTM through Dec 2025 was $1.7 million, a 26.69% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 26.82% from the prior year.
- Non Operating Income climbed to $483000.0 in Q4 2025 per DMAC's latest filing, from $419000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $709000.0 in Q4 2023 and bottomed at -$27000.0 in Q3 2021.
- The 5-year median for Non Operating Income is $263500.0 (2023), against an average of $291666.7.
- Across the five-year window, Non Operating Income plunged 121.09% in 2021 and jumped 3171.43% in 2022, its largest moves.
- Year by year, Non Operating Income stood at $7000.0 in 2021, then soared by 3171.43% to $229000.0 in 2022, then jumped by 209.61% to $709000.0 in 2023, then decreased by 25.53% to $528000.0 in 2024, then fell by 8.52% to $483000.0 in 2025.
- Per Business Quant, the three latest DMAC Non Operating Income figures stand at $483000.0 (Q4 2025), $419000.0 (Q3 2025), and $314000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 314,000.00 |
| Dec 31, 2024 | 528,000.00 |
| Sep 30, 2024 | 616,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Dec 31, 2023 | 709,000.00 |
| Sep 30, 2023 | 693,000.00 |
| Jun 30, 2023 | 271,000.00 |
| Mar 31, 2023 | 256,000.00 |
| Dec 31, 2022 | 229,000.00 |
| Sep 30, 2022 | 76,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | -27,000.00 |
| Jun 30, 2021 | 98,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 75,000.00 |
| Sep 30, 2020 | 128,000.00 |